Table 5: Anti-rejection treatments and outcomes received by AMR patients.
Therapy after rejection |
N (%) |
Hemodialysis despite treatment after 1 month(N-%) |
Hemodialysis despite treatment after 3 months(N-%) |
Corticosteroids+Plasmapheresis+IVIG |
8 (25) |
4(30.8) |
5(33.3) |
Corticosteroids +IVIG+ Rituximab |
13 (40.6) |
3(23.1) |
4(26.7) |
Corticosteroids+Plasmapheresis+IVIG+ Rituximab |
11 (34.4) |
6(46.2) |
6(40.0) |